Insider Trading activities of Dicerna Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dicerna Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dicerna Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Dicerna Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is DRNA. The reporting company's CIK number is 1399529.
The total value of stock buying since 2005 is $38,336,508.
The total value of stock sales since 2005 is $37,274,032.
The total value of stock option exercises since 2005 is $584,527.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Dicerna Pharmaceuticals Inc (DRNA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-01 0 $0 0 $0 360 $1,231
2017-12 285,000 $1,995,000 0 $0 13,745,272 $0
2016-11 33,100 $122,643 23,766 $83,656 0 $0
2016-05 5,000 $16,365 0 $0 0 $0
2016-02 0 $0 0 $0 34,722 $118,749
2015-02 0 $0 37,532 $976,582 0 $0
2014-12 0 $0 0 $0 2,500 $8,550
2014-11 0 $0 536,129 $5,627,405 0 $0
2014-10 0 $0 117,778 $1,277,613 0 $0
2014-03 0 $0 786,138 $29,308,776 0 $0
2014-02 2,400,000 $36,000,000 0 $0 0 $0
2014-01 13,500 $202,500 0 $0 123,794 $421,343
2013-11 0 $0 0 $0 10,133 $34,654

Table 2. Detailed insider stock purchases, sales, and option exercises of Dicerna Pharmaceuticals Inc insiders (DRNA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-01-26 Langer Dennis (Director) Option Ex 360 3.42 1,231
2017-12-18 Koppel Adam (Director) Buy 285,000 7.00 1,995,000
2017-12-18 Koppel Adam (Director) Option Ex 8,454,388 .00 0
2017-12-18 Kolchinsky Peter Option Ex 2,645,442 .00 0
2017-12-18 Ra Capital Healthcare Fund Lp Option Ex 2,645,442 .00 0
2016-11-16 Langer Dennis (Director) Sale 23,766 3.52 83,656
2016-11-15 Fambrough Douglas (Chief Executive Officer) Buy 16,500 3.63 59,895
2016-11-14 Fambrough Douglas (Chief Executive Officer) Buy 16,600 3.78 62,748
2016-05-12 Weissman James B (Chief Business Officer) Buy 5,000 3.27 16,365
2016-02-03 Langer Dennis (Director) Option Ex 34,722 3.42 118,749
2015-02-20 Kaneko Yasunori (Other) Sale 37,532 26.02 976,582
2014-12-17 Fambrough Douglas (Chief Executive Officer) Option Ex 2,500 3.42 8,550
2014-11-25 Deerfield Private Design International Ii, L.p. Sale 121,965 11.50 1,402,597
2014-11-24 Deerfield Private Design International Ii, L.p. Sale 100,000 11.54 1,154,500
2014-11-21 Deerfield Private Design International Ii, L.p. Sale 100,000 11.00 1,100,000
2014-11-07 Deerfield Private Design International Ii, L.p. Sale 214,164 9.20 1,970,308
2014-10-15 Deerfield Private Design International Ii, L.p. Sale 51,449 10.01 515,004
2014-10-14 Deerfield Private Design International Ii, L.p. Sale 36,115 11.02 397,987
2014-10-10 Deerfield Private Design International Ii, L.p. Sale 30,214 12.07 364,622
2014-03-18 Brookside Capital Trading Fund, L.p. (10% Owner) Sale 264,937 38.19 10,116,619
2014-03-17 Brookside Capital Trading Fund, L.p. (10% Owner) Sale 9,301 36.50 339,486
2014-03-14 Brookside Capital Trading Fund, L.p. (10% Owner) Sale 250,400 35.41 8,867,916
2014-03-12 Brookside Capital Trading Fund, L.p. (10% Owner) Sale 1,500 37.77 56,655
2014-03-11 Brookside Capital Trading Fund, L.p. (10% Owner) Sale 260,000 38.19 9,928,100
2014-02-04 Deerfield Private Design International Ii, Ltd. Buy 1,000,000 15.00 15,000,000
2014-02-04 Ra Capital Healthcare Fund Lp Buy 1,000,000 15.00 15,000,000
2014-02-04 Kaneko Yasunori (10% Owner) Buy 200,000 15.00 3,000,000
2014-02-04 Hoffman Stephen J (Director) Buy 200,000 15.00 3,000,000
2014-01-29 Weissman James B (Chief Business Officer) Buy 1,000 15.00 15,000
2014-01-29 Fambrough Douglas (Chief Executive Officer) Buy 5,000 15.00 75,000
2014-01-29 Madden David (Director) Buy 7,500 15.00 112,500
2014-01-27 Weissman James B (Chief Business Officer) Option Ex 11,283 3.24 36,556
2014-01-24 Madden David (Director) Option Ex 112,511 3.42 384,787
2013-11-11 Fambrough Douglas (Chief Executive Officer) Option Ex 9,300 3.42 31,806
2013-11-05 Weissman James B (Chief Business Officer) Option Ex 833 3.42 2,848

Insider trading activities including stock purchases, stock sales, and option exercises of DRNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dicerna Pharmaceuticals Inc (symbol DRNA, CIK number 1399529) see the Securities and Exchange Commission (SEC) website.